BioRegenx, Inc.
BRGX
$0.0133
-$0.0015-10.14%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -246.73% | -608.38% | -323.28% | -1,314.55% | -- |
| Total Depreciation and Amortization | 303.02% | 52,393.75% | -- | 114,525.00% | -- |
| Total Amortization of Deferred Charges | 339.29% | -- | 655.93% | 510.17% | -- |
| Total Other Non-Cash Items | 310.85% | 775.08% | 100.54% | 194,211.11% | -- |
| Change in Net Operating Assets | 867.85% | 233.80% | -70.38% | -78.36% | -- |
| Cash from Operations | 74.76% | 69.27% | -164.35% | -169.44% | -- |
| Capital Expenditure | 310.67% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 9,228.15% | 9,350.40% | -- | -- | -- |
| Cash from Investing | 4,932.95% | 9,457.02% | 167,880.00% | 167,880.00% | -- |
| Total Debt Issued | -139.46% | 107.05% | 109.86% | 110.31% | -- |
| Total Debt Repaid | 158.47% | 112.19% | 109.13% | 105.57% | -- |
| Issuance of Common Stock | -- | -- | -35.33% | -21.48% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1,504.22% | -1,616.31% | -1,698.31% | -1,502.65% | -- |
| Foreign Exchange rate Adjustments | -101.33% | -84.57% | -110.15% | -96.95% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 90.87% | 86.37% | -88.94% | -160.69% | -- |